WBA - Walgreens Expands Specialty Pharmacy Business To Include Gene and Cell Services: Details | Benzinga

Retail pharmacy giant Walgreens Boots Alliance Inc (NASDAQ:WBA) is bolstering its specialty pharmacy services, aiming to enhance patient outcomes and value for stakeholders.

The company unveiled Walgreens Specialty Pharmacy, an encompassing initiative to cater to patients with complex, chronic conditions while fostering profitable partnerships.

Read Next: Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business Contract

Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company’s healthcare offerings.

Anchored by an 18,000-square-foot Innovation Center in Pittsburgh, Pennsylvania, the initiative focuses on managing therapy ...

Full story available on Benzinga.com